coagulopathy


Also found in: Dictionary, Wikipedia.

coagulopathy

 [ko-ag″u-lop´ah-the]
any disorder of blood coagulation.
consumption coagulopathy disseminated intravascular coagulation.

co·ag·u·lop·a·thy

(kō'ag-yū-lop'ă-thē),
A disease affecting the coagulability of the blood.

coagulopathy

/co·ag·u·lop·a·thy/ (ko-ag″u-lop´ah-the) any disorder of blood coagulation.
consumption coagulopathy  disseminated intravascular coagulation.

coagulopathy

[kō·ag′yəlop′əthē]
a pathologicalondition that reduces the ability of the blood to coagulate, resulting in uncontrolled bleeding.

coagulopathy

Hematology A clotting defect in which bleeding does not stop in the usual time period Etiology Hemophilia, drug-induced defects–eg, aspirin, thrombocytopenia, liver disease, Von Willebrand's disease. See Consumption coagulopathy, DIC, Leukemic coagulopathy.

co·ag·u·lop·a·thy

(kō-ag'yū-lop'ă-thē)
A disease affecting the coagulability of the blood.

Coagulopathy

A disorder in which blood is either too slow or too quick to coagulate (clot).
Mentioned in: Cerebral Palsy

coagulopathy

any disorder of blood coagulation. See also hemophilia.

consumption coagulopathy
a bleeding tendency due to a reduction in clotting factors caused by their utilization. See also disseminated intravascular coagulation.
disseminated intravascular coagulopathy (DIC)
see disseminated intravascular coagulation.
hepatic coagulopathy
impaired synthesis of most clotting factors, including factors I, II, V, VII, IX and X, as well as other substances involved in the fibrinolytic system, in severe liver disease can cause significant abnormalities in coagulation.
References in periodicals archive ?
Laboratory findings associated with disseminated intravascular coagulopathy (DIC) were positive from the 14th postnatal day.
The viper bite cases presented with significant local reaction and coagulopathy.
Acute hepatic failure and coagulopathy associated with xylitol ingestion in eight dogs.
Preoperative coagulopathy was the strongest factor predicting the need for re-operation, vascular complications, and hemorrhagic complications.
KMS was considered in the patient who had wide spread vascularized giant hemangiomateous mass with thrombocytopenia and consumption coagulopathy.
Assessment of shock, anemia and coagulopathy at admission (first 15 mins of care) and at the end of DCS or admission to ICU was agreed and protocolized.
Yet to be tested directly on patients, the technology, which is in the early prototype phase, helps clinicians decide whether a patient is suffering from internal bleeding and needs a blood transfusion by analysing blood for signs of coagulopathy.
Haemorrhagic shock, however, is the leading cause of early potentially preventable trauma deaths, and recognition of the acute coagulopathy of traumatic shock (ACoTS) has made this increasingly amenable to interventions that result in reductions in morbidity and mortality.
Similarly, monitoring and management of coagulopathy and use of pharmacological agents also vital in managing such challenging situations.